Moreover, TFPI inhibited breast cancer cell proliferation and invasion by downregulating the extracellular signal-regulated kinase (ERK)/p38 mitogen-activated protein kinases (MAPK) signaling pathway [53]. The gene discussed is MAPK14; the disease is breast carcinoma.